- Pressemitteilung BoxID 131316
Eckert & Ziegler resolves capital increase
The shareholders of the company will be granted a purchase right. Moreover, the shareholders are offered an option to oversubscribe. Parallel to this, the shares that have not been subscribed according to the legal subscription right are offered to interested investors at the subscription price within the framework of a private placement. A trade of subscription rights via the stock exchange is not possible. The new shares will not be permitted to be traded on the regulated market until further notice so that no stock market trading will take place. The company intends to effect the listing of the new shares to become effective on 01-31-2010. BankM, representation of the biw Bank für Investments und Wertpapiere AG, has been commissioned with monitoring the capital increase.
It is intended to use the influx of funds from the capital increase particularly for the extension of the Environmental Services segment and for additional acquisitions of companies. The Environmental Services segment, which was added in early 2009 with the acquisition of Nuclitec GmbH, deals with the safe disposal of low- and medium-level radioactive waste. "With the beginning of operation of Schacht Konrad, a billion euro market is being created here. The retrieval of radioactive waste from the pit at Asse alone causes costs amounting to 0.9 to 3.7 billion EUR. We are hopeful that we can participate in the project with our "Competence Center for Safe Waste Disposal GmbH" ("Kompetenzzentrum für sichere Entsorgung GmbH"), which is a spin-off of Nuclitec", Dr. Andreas Eckert, Chief Executive Officer of Eckert & Ziegler AG explains. The Competence Center has the experience and in particular the infrastructure for the conditioning of Konrad containers and it has a special approval for the transport of radioactive waste in Germany across the borders of federal states. It is planned to invest some 10 million EUR in the extension of capacities to be able to cover the existing and the expected demand. To be able to actively participate in the consolidation in the business segments Industry and Therapy and to pursue the international expansion, existing and future acquisition opportunities shall be used increasingly. Eckert & Ziegler AG focuses on cutting edge technologies in the field of radioisotopes, and with a head count of about 520 employees it is one of the largest manufacturers in the world of radioactive components for the science, medicine and industry sectors. The company expects sales of EUR 100 million and earnings per share of about EUR 1.80 for the current year.
Diese Pressemitteilungen könnten Sie auch interessieren
Mit dem neu verabschiedeten Betriebsrentenstärkungsgesetz (BRSG) soll die Betriebsrente attraktiver werden – allerdings mit einem Nachteil für...
Riester-Sparer sollten ihren Vertrag einmal jährlich prüfen. Denn jegliche Gehaltserhöhung, auch per Tarifabschluss oder Berufsgruppensprung,...